Radiation Exposure in Nonvascular Fluoroscopy-Guided Interventional Procedures

Purpose

To investigate the radiation exposure in non-vascular fluoroscopy guided interventions and to search strategies for dose reduction.

Materials and Methods

Dose area product (DAP) of 638 consecutive non-vascular interventional procedures of one year were analyzed with respect to different types of interventions; gastrointestinal tract, biliary interventions, embolizations of tumors and hemorrhage. Data was analyzed with special focus on the fluoroscopy doses and frame doses. The third quartiles (Q3) of fluoroscopy dose values were defined in order to set a reference value for our in-hospital practice.

Results

Mean fluoroscopy times of gastrostomy, jejunostomy, right and left sided percutaneous biliary drainage, chemoembolization of the liver and embolization due to various hemorrhages were 5.9, 8.6, 13.5, 16.6, 17.4 and 25.2 min, respectively. The respective Q3 total DAP were 52.9, 73.3, 155.1, 308.4, 428.6 and 529.3 Gy*cm². Overall, around 66% of the total DAP originated from the radiographic frames with only 34% of the total DAP applied by fluoroscopy (P < 0.001). The investigators experience had no significant impact on the total DAP applied, most likely since there was no stratification to intervention-complexity.

Conclusion

To establish Diagnostic Reference Levels (DRLs), there is a need to establish a registry of radiation dose data for the most commonly performed procedures. Documentation of interventional procedures by fluoroscopy “grabbing” has the potential to considerably reduce radiation dose applied and should be used instead of radiographic frames whenever possible.     

10种介入诊疗程序中患者的辐射剂量调查

目的 调查研究介入诊疗程序中患者的受照剂量,评估其放射诊疗风险.方法 利用配置有符合IEC 60601-2标准的穿透型电离室的飞利浦Allura Xper FD20 DSA系统,收集记录10种介入诊疗程序共198例患者的剂量参数,估算出可供评估皮肤损伤的最高皮肤剂量及有效剂量.结果 累计透视时间范围为2.1～80.9 min,摄影帧数范围为15～678帧,剂量面积乘积范围为11～825 Gy·cm2,累计剂量范围为24～3374 mGy.有16例患者最高皮肤剂量超过1 Gy,79例患者有效剂量大于20 mSv.结论 有部分病例的最高皮肤剂量超过了皮肤损伤阈值,所以对患者的放射防护应给予足够的重枧.

Abstract：

Objective To investigate radiation dose to the patients undergoing interventional radiology and make radiation risk assessment.Methods Data was collected on 198 instances of 10 interventional radiology procedures by using Philips Allura Xper FD20 DSA, which was equipped with the transparent ionization chamber system in compliance with IEC 60601-2.Patient peak skin dose and effective dose were estimated.Results Cumulative fluoroscopy time was 2.1 - 80.9 min, and number of images monitored for PSD were above 1 Gy and 79 cases monitored for E were above 20 mSv.Conclusions Substantial number of cases exceeded the dose threshold for erythema.Due attention should be paid to radiation protection of patients.     

肝动脉化疗栓塞治疗肝癌患者的X射线辐射评价

目的　研究经肝动脉化疗栓塞 (THACE)治疗肝癌过程中 ,患者受到的X射线辐射 ,为THACE放射防护提供依据。方法　回顾性分析 82例HCC患者的辐射剂量资料 ,DSA机 (Angiostar Plus)配置穿透电离室型剂量监测系统 (DiamentorK1andDiamentorED) ,在线读取面积剂量乘积DAP(cGy cm2 )和入射表面剂量ESD(mGy) ,采用Monte Carlo转换因子估算有效剂量ED(mSv)。并分析近期 10例THACE患者 ,在提高基值管电压、减低透视脉冲频率和摄影帧数下对辐射剂量的影响。结果　 82例HCC患者透视时间 (35 3± 2 1 1)min ,摄影 (2 34± 10 8)帧 ,DAP为 (2 174 8± 12 4 2 4 )cGy cm2 ,ESD为 (96 4± 6 32 )mGy ,ED为 (34 8± 19 9)mSv。透视对总DAP的贡献 (2 4 0± 12 7) %小于摄影 (75 9± 12 7) % ,透视对ESD值的贡献 (4 9 8± 14 9) % ,与摄影相似 (5 1 6± 14 2 ) %。近期的 10例THACE患者的每分钟透视剂量、每帧摄影剂量及总剂量都比HCC患者明显降低。结论　在THACE过程中患者受到一次性较大剂量X射线照射。适度提高基值管电压、减低透视脉冲频率和缩减摄影帧数 ,可以有效降低患者的辐射剂量     

用胶片法对心脏介入程序中患者峰值皮肤剂量测量研究

目的 采用胶片法对进行心血管介入手术中患者所受峰值皮肤剂量（PSD）进行测量研究,包括冠状动脉血管造影术（CA）和经皮穿刺腔内冠状动脉成形术（PTCA）。方法 选用Gafchromic XR-RV3胶片在两家医院进行患者峰值皮肤剂量的测量。手术时将胶片放在患者身下的诊视床上。记录手术中监视器上显示的kV、mA、透视时间、剂量面积乘积（DAP）、参考点累积剂量等相关信息。采用Epson V750平板扫描仪对胶片进行分析扫描及分析,选用FilmQA软件分别测量图像的红、绿、蓝三色通道的像素值,使用红通道数据计算患者的 PSD。对PSD与设备显示参数进行相关分析,对相关的变量进行多元线性回归分析。结果 共测量CA手术26例,CA+PTCA手术19例。CA手术中,透视时间最高为17.62 min,累积剂量和DAP最大分别为1 498.50 mGy和109.68 Gy ·cm²,PSD最大为361.20 mGy。CA+PTCA手术中,曝光时间最长为64.48 min,累积剂量和DAP最大分别为6 976.20 mGy和5 336.00 Gy ·cm²,17例患者的PSD在1 Gy以内,1例患者PSD在1~2 Gy之间,1例患者PSD超出了发生皮肤损伤2 Gy的阈值,达到了2 195.70 mGy。CA程序中,患者PSD与DAP相关（R²=0.815,P<0.05）,CA+PTCA程序中,患者PSD与累积剂量相关（R²=0.916,P<0.05）。结论 心脏介入放射学程序中部分患者的PSD会超出ICRP建议的发生皮肤确定性效应的2 Gy阈值。DSA设备上显示的剂量相关的参数,只能粗略估算患者PSD的大小。使用XR-RV3胶片精确测量介入手术中患者的峰值皮肤剂量是一种非常快捷、有效的方法。     

Patient radiation doses and references levels in interventional radiology

PURPOSE: To set Diagnostic Reference Levels (DRLs) in interventional radiology by means of dose area product (DAP) measurements and the grouping of homogeneous procedures, and to quantify the associated errors in the DRL estimates. To evaluate the Mean Effective Doses per single procedure. MATERIALS AND METHODS: Interventional radiology procedures were divided into four main groups: neuroradiological, vascular, extravascular and paediatric. Neuroradiological and vascular procedures were further divided into diagnostic and interventional procedures. Starting from DAP and total fluoroscopy time measurements in 1,256 patients, the DRLs were determined for 17 procedures, together with an estimate of their uncertainty. The correlation between fluoroscopy time and DAP was assessed. Mean effective dose estimates were obtained from measured DAP values and from the analysis of the dosimetric data reported in the literature for similar procedures. RESULTS: The main features of DAP distributions are long high-dose tails, indicating asymmetric distributions, together with a large interquartile range. Rounded third-quartile values of DAP distributions showed a large range in the procedures taken into consideration. Values of 147, 198, 338 Gy cm(2)were obtained for supra-aortic angiography, cerebral angiography and embolization. Values of 86-101 and 459-438 Gy cm(2)were obtained for diagnostic and interventional vascular procedures on the lower limbs and on the abdomen, respectively. Values of 25-33 Gy cm(2)were obtained for retrograde cystourethrographies and ERCP, and values of 62-158 Gy cm(2)were obtained for nephrostomy and percutaneous transhepatic cholangiography. The correlation between total fluoroscopy time and the DAP values was poor. Mean effective dose estimates showed lower values for extravascular procedures (4.8-28.2 mSv), intermediate values for neuroradiological procedures (12.6-32.9 mSv) and higher values for vascular procedures involving the abdomen (36.5-86.8 mSv). DISCUSSION: DAP values were generally higher in vascular than in extravascular procedures. In generally, interventional vascular procedures show higher DAP values than the corresponding diagnostic procedures, with the exception of the abdominal region where the values were similar. Extravascular procedures with percutaneous access show significantly higher DAP values than those with endoscopic access. Total fluoroscopy time is a poor predictor of patient doses in interventional radiology. CONCLUSIONS: The systematic recording of DAP values, together with adequate grouping of similar procedures makes it possible to establish stable DRLs on a local basis and to carry out dosimetric evaluations, although on a statistical rather than individual basis. Patient radiation doses during interventional radiological procedures may be high, particularly when the abdominal region is involved.     

Contemporary Interventional Radiology Dosimetry: Analysis of 4,784 Discrete Procedures at a Single Institution

PurposeTo report dosimetry of commonly performed interventional radiology procedures and compare dose analogues to known reference levels.Materials and MethodsDemographic and dosimetry data were collected for gastrostomy, nephrostomy, peripherally inserted central catheter placement, visceral arteriography, hepatic chemoembolization, tunneled catheter placement, inferior vena cava filter placement, vascular embolization, transjugular liver biopsy, adrenal vein sampling, transjugular intrahepatic portosystemic shunt (TIPS) creation, and biliary drainage between June 12, 2014, and April 26, 2018, using integrated dosimetry software. In all, 4,784 procedures were analyzed. The study included 2,691 (56.2%) male subjects and 2,093 (43.8%) female subjects with mean age 55 ± 21 years (range: 0-104 years) and with mean weight of 76.9 ± 29.4 kg (range: 0.9-268.1 kg). Fluoroscopy time, dose area product (DAP), and reference dose were evaluated.ResultsTIPS had the highest mean fluoroscopy time (49.1 ± 16.0 min) followed by vascular embolization (25.2 ± 11.4 min), hepatic chemoembolization (18.8 ± 12.5 min), and visceral arteriography (17.7 ± 3.2 min). TIPS had the highest mean DAP (429.2 ± 244.8 grays per square centimeter [Gy·· cm²]) followed by hepatic chemoembolization (354.6 ± 78.6 Gy·· cm²), visceral arteriography (309.5 ± 39.0 Gy·· cm²), and vascular embolization (298.5 ± 29 Gy·· cm²). TIPS was associated with the highest mean reference dose (2.002 ± 1.420 Gy) followed by hepatic chemoembolization (1.746 ± 0.435 Gy), vascular embolization (1.615 ± 0.381 Gy), and visceral arteriography (1.558 ± 1.720 Gy). Of the six procedures available for comparison with the reference levels, the mean fluoroscopy time, DAP, and reference dose for each procedure were below the proposed reference levels.ConclusionAdvances in image acquisition technology and radiation safety protocols have significantly reduced the radiation exposure for a variety of interventional radiology procedures.     

Patient Radiation Dose in Diagnostic and Interventional Procedures for Intracranial Aneurysms: Experience at a Single Center

Objective

To assess patient radiation doses during cerebral angiography and embolization of intracranial aneurysms in a large sample size from a single center.

Materials and Methods

We studied a sample of 439 diagnostic and 149 therapeutic procedures for intracranial aneurysms in 480 patients (331 females, 149 males; median age, 57 years; range, 21-88 years), which were performed in 2012 with a biplane unit. Parameters including fluoroscopic time, dose-area product (DAP), and total angiographic image frames were obtained and analyzed.

Results

Mean fluoroscopic time, total mean DAP, and total image frames were 12.6 minutes, 136.6 ± 44.8 Gy-cm², and 251 ± 49 frames for diagnostic procedures, 52.9 minutes, 226.0 ± 129.2 Gy-cm², and 241 frames for therapeutic procedures, and 52.2 minutes, 334.5 ± 184.6 Gy-cm², and 408 frames for when both procedures were performed during the same session. The third quartiles for diagnostic reference levels (DRLs) were 14.0, 61.1, and 66.1 minutes for fluoroscopy time, 154.2, 272.8, and 393.8 Gy-cm² for DAP, and 272, 276, and 535 for numbers of image frames in diagnostic, therapeutic, and both procedures in the same session, respectively. The proportions of fluoroscopy in DAP for the procedures were 11.4%, 50.5%, and 36.1%, respectively, for the three groups. The mean DAP for each 3-dimensional rotational angiographic acquisition was 19.2 ± 3.2 Gy-cm². On average, rotational angiography was used 1.4 ± 0.6 times/session (range, 1-4; n = 580).

Conclusion

Radiation dose in our study as measured by DAP, fluoroscopy time and image frames did not differ significantly from other reported DRL studies for cerebral angiography, and DAP was lower with fewer angiographic image frames for embolization. A national registry of radiation-dose data is a necessary next step to refine the dose reference level.     

Preliminary reference levels in interventional cardiology

This article describes the European DIMOND approach to defining reference levels (RLs) for radiation doses delivered to patients during two types of invasive cardiology procedures, namely coronary angiography (CA) and percutaneous transluminal coronary angioplasty (PTCA). Representative centres of six European countries recorded patients' doses in terms of dose-area product (DAP), fluoroscopy time and number of radiographic exposures, using X-ray equipment that has been subject to constancy testing. In addition, a DAP trigger level for cardiac procedures which should alert the operator to possible skin injury, was set to 300 Gy×cm². The estimation of maximum skin dose was recommended in the event that a DAP trigger level was likely to be exceeded. The proposed RLs for CA and PTCA were for DAP 45 Gy×cm² and 75 Gy×cm², for fluoroscopy time 7.5 min and 17 min and for number of frames 1250 and 1300, respectively. The proposed RLs should be considered as a first approach to help in the optimisation of these procedures. More studies are required to establish certain "tolerances" from the proposed levels taking into account the complexity of the procedure and the patient's size.     

Evaluation of patient doses in interventional radiology]

PURPOSE: To verify the suitability of indicative quantities to evaluate the risk related to patient exposure, in abdominal and vascular interventional radiology, by the study of correlations between dosimetric quantities and other indicators. MATERIAL AND METHODS: We performed in vivo measurements of entrance skin dose (ESD) and dose area product (DAP) during 48 procedures to evaluate the correlation among dosimetric quantities, and an estimation of spatial distribution of exposure and effective dose (E). To measure DAP we used a transmission ionization chamber and to evaluate ESD and its spatial distribution we used radiographic film packed in a single envelope and placed near the patient's skin. E was estimated by a calculation software using data from film digitalisation. RESULTS: From the data derived for measurements in 27 interventional procedures on 48 patients we obtained a DAP to E conversion factor of 0.15 mSv / Gy cm2, with an excellent correlation (r=.99). We also found a good correlation between DAP and exposure parameters such as fluoroscopy time and number of images. The greatest effective dose was evaluated for a multiple procedure in the hepatic region, with a DAP value of 425 Gy cm2. The greatest ESD was about 550 mGy. For groups of patients undergoing similar interventional procedures the correlation between ESD and DAP had conversion factors from 6 to 12 mGy Gy-1 cm-2. CONCLUSION: The evaluation of ESD and E by slow films represents a valid method for patient dosimetry in interventional radiology. The good correlation between DAP and fluoroscopy time and number of images confirm the suitability of these indicators as basic dosimetric information. All the ESD values found are lower than threshold doses for deterministic effects.     

Optimizing Staff Dose in Fluoroscopy-Guided Interventions by Comparing Clinical Data with Phantom Experiments

PurposeTo evaluate conditions for minimizing staff dose in interventional radiology, and to provide an achievable level for radiation exposure reduction.Materials and MethodsComprehensive phantom experiments were performed in an angiography suite to evaluate the effects of several parameters on operator dose, such as patient body part, radiation shielding, x-ray tube angulation, and acquisition type. Phantom data were compared with operator dose data from clinical procedures (n = 281), which were prospectively acquired with the use of electronic real-time personal dosimeters (PDMs) combined with an automatic dose-tracking system (DoseWise Portal; Philips, Best, The Netherlands). A reference PDM was installed on the C-arm to measure scattered radiation. Operator exposure was calculated relative to this scatter dose.ResultsIn phantom experiments and clinical procedures, median operator dose relative to the dose-area product (DAP) was reduced by 81% and 79% in cerebral procedures and abdominal procedures, respectively. The use of radiation shielding decreased operator exposure up to 97% in phantom experiments; however, operator dose data show that this reduction was not fully achieved in clinical practice. Both phantom experiments and clinical procedures showed that the largest contribution to relative operator dose originated from left-anterior-oblique C-arm angulations (59%–75% of clinical operator exposure). Of the various x-ray acquisition types used, fluoroscopy was the main contributor to procedural DAP (49%) and operator dose in clinical procedures (82%).ConclusionsAchievable levels for radiation exposure reduction were determined and compared with real-life clinical practice. This generated evidence-based advice on the conditions required for optimal radiation safety.     

心血管病介入操作时患者受照剂量研究

目的 对心血管介入手术中患者所受辐射剂量及与辐射剂量相关的指标进行采集和分析,为改善患者的辐射防护提供依据.方法 对在省属三级甲等医院进行的26例完整的心血管介入手术的患者进行临床数据采集,按手术类别分成冠状动脉血管造影术(CA)及行冠状动脉血管造影术(CA)后继续行经皮穿刺腔内冠状动脉成形术(PTCA)两组,采用TLD个人剂量计照射野矩阵测量法,检测患者荧光照射时间、入射皮肤剂量(ESD)、最高皮肤剂量(PSD)、剂量-面积乘积(DAP)等指标,用TLD测量在模拟心血管手术条件下体模器官剂量.结果 荧光透视时间为(17.7±15.6)min,范围为0.80～42.4 min;ESD范围为(159±138)mGy,4.40～459 mGy;PSD范围为(769±705)mGy,22.6～2.43×103mGy.CA+PTCA组的荧光照射时间、ESD、PSD均大于CA组,差异有统计学意义.最大皮肤受照剂量与透视时间有较好的相关性(r=0.84,P＜0.01).结论 心血管病放射性介入操作时,可通过透视时间来估算最大皮肤受照剂量.

Abstract：

Objective To collect and analyze the radiation dose to patients in cardiovascular interventional procedures and the radiation dose-related indicators,in order to provide a basis for improving radiation protection of patients.MethodsThe clinical data of 26 cases of complete cardiovascular interventional procedures was collected in the municipal Grade A Class Three hospitals,including coronary angiography (CA) and percutaneous transluminal coronary angioplasty (PTCA),and the patient-received radiation doses and other related factors was studied.TLD personal dosimeter radiation field matrix method was used to measure fluorescence time,the entrance skin dose (ESD),the peak skin dose (PSD),dosearea product (DAP) and other indicators.TLD was used to measure the organ dose of the phantom under the cardiovascular interventional procedure condition.ResultsThe fluoroscopy time was (17.7 ±15.6) min during the range of 0.80-42.4 min.The average entrance skin dose (ESD) was (159 ± 138)mGy during the range of 4.40-459 mGy.The peak skin dose (PSD) was (769 ± 705) mGy during the range of 22.6 - 2.43 × 103mGy.The fluorescence time,entrance skin dose (ESD) ,peak skin dose (PSD) of the group CA + PTCA are greater than the group CA and the difference has statistical significan.The peak skin dose and the fluoroscopy time have good linear correlation (r = 0.84,P ＜ 0.01 ).Conclusion The peak skin dose the patient received in cardiovascular interventional radiological operation can be estimated through the fluoroscopy time.     

How to set up and apply reference levels in fluoroscopy at a national level

A nationwide survey was launched to investigate the use of fluoroscopy and establish national reference levels (RL) for dose-intensive procedures. The 2-year investigation covered five radiology and nine cardiology departments in public hospitals and private clinics, and focused on 12 examination types: 6 diagnostic and 6 interventional. A total of 1,000 examinations was registered. Information including the fluoroscopy time (T), the number of frames (N) and the dose-area product (DAP) was provided. The data set was used to establish the distributions of T, N and the DAP and the associated RL values. The examinations were pooled to improve the statistics. A wide variation in dose and image quality in fixed geometry was observed. As an example, the skin dose rate for abdominal examinations varied in the range of 10 to 45 mGy/min for comparable image quality. A wide variability was found for several types of examinations, mainly complex ones. DAP RLs of 210, 125, 80, 240, 440 and 110 Gy cm² were established for lower limb and iliac angiography, cerebral angiography, coronary angiography, biliary drainage and stenting, cerebral embolization and PTCA, respectively. The RL values established are compared to the data published in the literature.     

五种介入程序中职业人员手部受照剂量水平的评估

目的 评估5种临床介入程序中,职业人员手部受照剂量水平。方法 选择北京4家医院进行5种介入程序的治疗,职业人员术中左右手各佩戴1枚热释光指环剂量计（TLD,LiF：Mg,Ti）,进行手部剂量当量H_p（0.07）监测,同时分别记录患者的透视电压、透视电流、透视时间、摄影数,总累积剂量、剂量面积乘积等影响因素信息,对影响因素进行分析。结果 本研究共监测5种介入程序,119例手术。对5种介入程序中职业人员左手与右手受照剂量进行分析,差异有统计学意义（t=1.99,P<0.05）。不同介入程序的第一术者手部受照剂量左手、右手差异均有统计学意义（F=455.83、116.45,P<0.01）。影响因素分析中,随着透视管电压,透视电流,透视时间,摄影数的增加,操作者手部剂量也增加（r=0.570、0.712、0.564、0.711,P<0.05）。将上述单因素分析有统计学意义的变量引入多元线性回归方程中,采用逐步回归法拟合方程。经拟合方程为y=225.763+1.862x₁-98.125x₂（F=22.726,P<0.05）。其中变量x₁为透视时间,x₂为摄影数。表明影响操作者手部剂量的主要因素是透视时间和摄影数。结论 在开展上述5种介入程序治疗时,第一术者的手部剂量最高,其次第二术者、助手或护士;5类介入程序中,第一术者的手部受照剂量水平高低排列为心脏起搏器植入术（PM） > 射频消融（RFA） > 冠状动脉血管造影术（CA） > 支架植入术（PTCA+PCI） > 脑动脉瘤介入术（ITCA）;大量开展PM手术时,第一术者手部的年当量剂量有可能超过限值。     

Radiation doses in interventional radiology procedures: the RAD-IR study: part I: overall measures of dose

PURPOSE: To determine patient radiation doses for interventional radiology and neuroradiology procedures, to identify procedures associated with higher radiation doses, and to determine the effects of various parameters on patient doses. MATERIALS AND METHODS: A prospective observational study was performed at seven academic medical centers. Each site contributed demographic and radiation dose data for subjects undergoing specific procedures in fluoroscopic suites equipped with built-in cumulative dose (CD) and dose-area-product (DAP) measurement capability compliant with International Electrotechnical Commission standard 60601-2-43. The accuracy of the dosimetry was confirmed by comprehensive measurements and by frequent consistency checks performed over the course of the study. RESULTS: Data were collected on 2,142 instances of interventional radiology procedures, 48 comprehensive physics evaluations, and 581 periodic consistency checks from the 12 fluoroscopic units in the study. There were wide variations in dose and statistically significant differences in fluoroscopy time, number of images, DAP, and CD for different instances of the same procedure, depending on the nature of the lesion, its anatomic location, and the complexity of the procedure. For the 2,142 instances, observed CD and DAP correlate well overall (r = 0.83, P <.000001), but correlation in individual instances is poor. The same is true for the correlation between fluoroscopy time and CD (r = 0.79, P <.000001). The correlation between fluoroscopy time and DAP (r = 0.60, P <.000001) is not as good. In 6% of instances (128 of 2,142), which were principally embolization procedures, transjugular intrahepatic portosystemic shunt (TIPS) procedures, and renal/visceral artery stent placements, CD was greater than 5 Gy. CONCLUSIONS: Most procedures studied can result in clinically significant radiation dose to the patient, even when performed by trained operators with use of dose-reducing technology and modern fluoroscopic equipment. Embolization procedures, TIPS creation, and renal/visceral artery stent placement are associated with a substantial likelihood of clinically significant patient dose. At minimum, patient dose data should be recorded in the medical record for these three types of procedures. These data should include indicators of the risk of deterministic effects as well as the risk of stochastic effects.     

Removal of the Antiscatter Grid During Routine Biliary Interventional Procedures Performed in a Flat-Panel Interventional Suite: Preliminary Data on Image Quality and Patient Radiation Exposure

Purpose

To determine whether grid removal during routine biliary interventional procedures performed in a flat-panel interventional suite results in adequate image quality and a significant decrease of patient radiation exposure.

Materials and Methods

Routine biliary interventional procedures were defined as those in which absence of fine image detail during fluoroscopy carries no procedural impact, including substitution of internal–external biliary drains (n = 25) or bilioplasty of benign biliary anastomotic strictures (n = 5). All patients had undergone a previous procedure in which the grid was used. Constant object-to-detector and source-to-image distance were maintained in each patient during the grid/no-grid procedures. The same fluoroscopy protocol was used for all examinations. The dose area product (DAP [cGy.cm²]) and procedure fluoroscopy time (seconds) were recorded for each procedure. DAP was normalized per unit of fluoroscopy time (nDAP [cGy.cm²/s]).

Results

In all procedures, image quality was considered adequate by two different interventional radiologists, and all procedures were successfully completed without significant changes in fluoroscopy time between the two groups (p = 0.13). In every procedure without the grid, nDAP was inferior compared with nDAP in procedures performed using the grid. The mean decrease in dose was 39.2 ± 23.5 % (p = 0.000001).

Conclusion

Our preliminary data show that removal of the grid during routine biliary procedures is feasible and results in a significant decrease of patient radiation exposure. This seems of particular relevance because most of these patients require frequent reintervention. Larger studies with more procedures are warranted to confirm these data.     

Reducing Radiation Dose in Pediatric Diagnostic Fluoroscopy

PurposeTo assess radiation dose in common pediatric diagnostic fluoroscopy procedures and determine the efficacy of dose tracking and dose reduction training to reduce radiation use.MethodsFluoroscopy time and radiation dose area product (DAP) were recorded for upper GIs (UGI), voiding cystourethrograms (VCUGs), and barium enemas (BEs) during a six-month period. The results were presented to radiologists followed by a 1-hour training session on radiation dose reduction methods. Data were recorded for an additional six months. DAP was normalized to fluoroscopy time, and Wilcoxon testing was used to assess for differences between groups.ResultsData from 1,479 cases (945 pretraining and 530 post-training) from 9 radiologists were collected. No statistically significant difference was found in patient age, proportion of examination types, or fluoroscopy time between the pre- and post-training groups (P ≥ .1), with the exception of a small decrease in median fluoroscopy time for VCUGs (1.0 vs 0.9 minutes, P = .04). For all examination types, a statistically significant decrease was found in the median normalized DAP (P < .05) between pre- and post-training groups. The median (quartiles) for pretraining and post-training normalized DAPs (μGy·m² per minute) were 14.36 (5.00, 38.95) and 6.67 (2.67, 17.09) for UGIs; 13.00 (5.34, 32.71) and 7.16 (2.73, 19.85) for VCUGs; and 33.14 (9.80, 85.26) and 17.55 (7.96, 46.31) for BEs.ConclusionsRadiation dose tracking with feedback, paired with dose reduction training, can reduce radiation dose during diagnostic pediatric fluoroscopic procedures by nearly 50%.     

Skin dose and dose-area product values in patients undergoing intracoronary brachytherapy

Entrance skin doses, dose-area product (DAP) values, fluoroscopy times and digital cine acquisition data were measured for 86 patients undergoing intracoronary brachytherapy procedures with beta sources, to estimate risk of skin injuries. Interventions were carried out in three dedicated X-ray interventional cardiology rooms equipped with X-ray systems operating in pulsed modes, with high filtration and edge filter options. Skin dose distribution was analysed in detail in 56 patients using slow films and thermoluminescent dosimetry. Digital recording of Digital Imaging and Communications in Medicine cine images also allowed analysis of the technical parameters used throughout the procedures. A protocol for clinical follow-up of these patients at the cardiology service is also presented, which prescribes special attention when a threshold dose is reached. Median values for DAP, fluoroscopy time and number of frames were 81.2 Gy cm(2), 17.5 min and 1569 frames, respectively, and maximum values were 323.3 Gy cm(2), 46.2 min and 3213 frames, respectively. In two cases, maximum skin doses in a procedure reached 3.5 Gy and 4.6 Gy. Comparing median values in this study, intracoronary brachytherapy involved approximately two-fold the DAP used in percutaneous transluminal coronary angioplasty procedures performed during the same period in the same catheterization laboratories, as a consequence of the need to monitor the radioactive source location used for the treatment of stenoses and the intravascular ultrasound. Special care must be paid in those cases of high dose in relation to potential patient skin injuries and late effects.     

Radiation protection value to the operator from augmented reality smart glasses in interventional fluoroscopy procedures using phantoms

IntroductionSmart glasses can be adapted to display radiographic images to allow clinician's gaze not to be directionally fixed or predetermined by computer monitor location. This study presents an analysis of eye lens dose during interventional fluoroscopy guided procedures, comparing fixed monitor positions against the use of smart glasses.MethodsUsing a head phantom (simulating the clinician), thermoluminescent dosimeters and lead shielded glasses, the dose to the eye was measured for different head ‘rotations and tilts’ for: gaze directed towards the main scattering source (patient/primary beam) to represent potential gaze direction if smart glasses are used; gaze directed to a range of potential computer monitor positions. An anthropomorphic pelvis phantom was utilised to simulate the patient. Accumulated dose rates (μGy sˉ¹) from five 10-second exposures at 75 kV 25.2 mAs were recorded.ResultsAn average DAP reading of 758.84 cGy cm² was measured during each 10 second exposure. Whilst wearing lead shielded glasses a 6.10 – fold reduction in dose rate to the lens is possible (p < 0.05). Influence of the direction of gaze by the clinician demonstrated a wide range of dose rate reduction from 3.13% (p = 0.16) to 143.69% (p < 0.05) when the clinician's gaze was towards the main scattering source. Increased dose rate to the clinician's eyes was received despite wearing lead shielded glasses, as the angle of gaze moved 45° and 90° from 0°.ConclusionIf the clinician's gaze is directed towards the main scattering source a potential exists for reducing eye lens dose compared with fixed location computer monitors. Introduction of lead lined smart glasses into interventional radiology may lead to improvements in patient care, reducing the need for the clinician to look away from the patient to observe a radiographic image.     

Has the introduction of an advanced practitioner led service had an impact on radiation dose for fluoroscopy guided lumbar punctures? A service review

IntroductionHistorically, procedures requiring fluoroscopic guidance such as myelography; barium and video swallows; and fluoroscopy guided lumbar punctures (LP) have been performed by radiologists with the assistance of radiographers. As the National Health Service (NHS) evolves, more responsibilities are being disseminated to specifically trained radiographers to relieve workload due to a national shortage of radiologists. One step taken by the trust was to train an Advanced Practitioner (AP) in fluoroscopy to perform fluoroscopy guided LPs. Clinical audit and service evaluations are required to ensure there is no impact on patient care as a result of changes in practice. Regardless of occupation, healthcare workers undertaking procedures must ensure the same standards of care for patients. Minimising radiation dose is a duty of all radiological professionals.MethodsThis retrospective review evaluated and compared examinations performed by a group of radiologists and an AP in terms of dose area product (DAP) and fluoroscopy screening time. A total of 300 X-ray guided LPs doses were reviewed and comparison between the radiation exposure data sets was performed to determine whether there was a significant difference between the two operator groups.ResultsThe study revealed that AP-performed LPs had a statistically significant lower DAP and fluoroscopy time (a mean of 4.21Gycm2 and 0.74min) compared to the radiologist-performed LPs (a mean of 5.72Gycm2 and 0.94min).ConclusionThe review demonstrates that patient dose is not detrimentally affected by the introduction of an advanced practitioner. It establishes that dose and screening time was significantly lower. It also highlights the effectiveness of APs in an evolving radiology department.Implications for practiceThese outcomes propose advanced practitioners in this area of expertise can expand their role from neuroradiographer with no detriment to patient dose. Despite the results, it is recognised that continuous appraisal is required to ensure that competencies are maintained, and high levels of care are sustained.     

Effect of Real-Time Radiation Dose Feedback on Pediatric Interventional Radiology Staff Radiation Exposure

PurposeTo measure and compare individual staff radiation dose levels during interventional radiologic (IR) procedures with and without real-time feedback to evaluate whether it has any impact on staff radiation dose.Materials and MethodsA prospective trial was performed in which individuals filling five different staff roles wore radiation dosimeters during all IR procedures during two phases: a 12-week “closed” phase (measurements recorded but display was off, so no feedback was provided) and a 17-week “open” phase (display was on and provided real-time feedback). Radiation dose rates were recorded and compared by Mann–Whitney U test.ResultsThere was no significant difference in median procedure time, fluoroscopy time, or patient dose (dose–area product normalized to fluoroscopy time) between the two phases. Overall, the median staff dose was lower in the open phase (0.56 µSv/min of fluoroscopy time) than in the closed phase (3.01 µSv/min; P < .05). The IR attending physician dose decreased significantly for procedures for which the physicians were close to the patient, but not for ones for which they were far away.ConclusionsA radiation dose monitoring system that provides real-time feedback to the interventional staff can significantly reduce radiation exposure to the primary operator, most likely by increasing staff compliance with use of radiation protection equipment and dose reduction techniques.